• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒小干扰 RNA (siRNA) 数据库。

A small interfering RNA (siRNA) database for SARS-CoV-2.

机构信息

Bioinformatics Graduate Program, Metrópole Digital Institute, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59078-400, Brazil.

Instituto do Cérebro, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59078-970, Brazil.

出版信息

Sci Rep. 2021 Apr 23;11(1):8849. doi: 10.1038/s41598-021-88310-8.

DOI:10.1038/s41598-021-88310-8
PMID:33893357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065152/
Abstract

Coronavirus disease 2019 (COVID-19) rapidly transformed into a global pandemic, for which a demand for developing antivirals capable of targeting the SARS-CoV-2 RNA genome and blocking the activity of its genes has emerged. In this work, we presented a database of SARS-CoV-2 targets for small interference RNA (siRNA) based approaches, aiming to speed the design process by providing a broad set of possible targets and siRNA sequences. The siRNAs sequences are characterized and evaluated by more than 170 features, including thermodynamic information, base context, target genes and alignment information of sequences against the human genome, and diverse SARS-CoV-2 strains, to assess possible bindings to off-target sequences. This dataset is available as a set of four tables, available in a spreadsheet and CSV (Comma-Separated Values) formats, each one corresponding to sequences of 18, 19, 20, and 21 nucleotides length, aiming to meet the diversity of technology and expertise among laboratories around the world. A metadata table (Supplementary Table S1), which describes each feature, is also provided in the aforementioned formats. We hope that this database helps to speed up the development of new target antivirals for SARS-CoV-2, contributing to a possible strategy for a faster and effective response to the COVID-19 pandemic.

摘要

新型冠状病毒病 2019(COVID-19)迅速演变为全球性大流行,因此需要开发能够针对 SARS-CoV-2 RNA 基因组并阻断其基因活性的抗病毒药物。在这项工作中,我们提供了一个针对 SARS-CoV-2 的小干扰 RNA(siRNA)靶点数据库,旨在通过提供广泛的可能靶点和 siRNA 序列来加速设计过程。siRNA 序列的特征和评估由 170 多个特征组成,包括热力学信息、碱基上下文、靶点基因和序列与人类基因组的比对信息,以及多种 SARS-CoV-2 毒株,以评估可能与脱靶序列的结合情况。该数据集以四个表的形式提供,以电子表格和 CSV(逗号分隔值)格式提供,每个表对应 18、19、20 和 21 个核苷酸长度的序列,旨在满足全球实验室在技术和专业知识方面的多样性。还提供了一个描述每个特征的元数据表(补充表 S1),也以上述格式提供。我们希望这个数据库能够帮助加快针对 SARS-CoV-2 的新型靶向抗病毒药物的开发,为 COVID-19 大流行的快速有效应对提供一种可能的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/cceb56ee6eb1/41598_2021_88310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/1307663794f3/41598_2021_88310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/5e4bc3b45f59/41598_2021_88310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/167562c01e36/41598_2021_88310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/cceb56ee6eb1/41598_2021_88310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/1307663794f3/41598_2021_88310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/5e4bc3b45f59/41598_2021_88310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/167562c01e36/41598_2021_88310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aab/8065152/cceb56ee6eb1/41598_2021_88310_Fig4_HTML.jpg

相似文献

1
A small interfering RNA (siRNA) database for SARS-CoV-2.新型冠状病毒小干扰 RNA (siRNA) 数据库。
Sci Rep. 2021 Apr 23;11(1):8849. doi: 10.1038/s41598-021-88310-8.
2
A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.一种设计潜在 siRNA 分子的计算方法,作为沉默 SARS-CoV-2 的核衣壳磷酸蛋白和表面糖蛋白基因的有前途的工具。
Genomics. 2021 Jan;113(1 Pt 1):331-343. doi: 10.1016/j.ygeno.2020.12.021. Epub 2020 Dec 13.
3
AGO CLIP-based imputation of potent siRNA sequences targeting SARS-CoV-2 with antifibrotic miRNA-like activity.基于 AGO CLIP 的 SARS-CoV-2 强效 siRNA 序列的推测,具有抗纤维化 miRNA 样活性。
Sci Rep. 2021 Sep 27;11(1):19161. doi: 10.1038/s41598-021-98708-z.
4
Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains.针对印度 SARS-CoV-2 株相关结构蛋白基因的有效 siRNAs 的计算研究与设计。
Comput Biol Chem. 2022 Jun;98:107687. doi: 10.1016/j.compbiolchem.2022.107687. Epub 2022 Apr 29.
5
Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences.自组装 siRNA 纳米颗粒靶向多个高度保守病毒序列抑制 SARS-CoV-2 复制。
Viruses. 2024 Jul 3;16(7):1072. doi: 10.3390/v16071072.
6
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.靶向基因组 SARS-CoV-2 RNA 的 siRNAs 可有效抑制病毒复制和传播。
Nucleic Acids Res. 2022 Jan 11;50(1):333-349. doi: 10.1093/nar/gkab1248.
7
Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2.设计一种有效的治疗性 siRNA 来沉默 SARS-CoV-2 的 RdRp 基因。
Infect Genet Evol. 2021 Sep;93:104951. doi: 10.1016/j.meegid.2021.104951. Epub 2021 Jun 2.
8
Developing effective siRNAs to reduce the expression of key viral genes of COVID-19.开发有效的小干扰RNA以降低新型冠状病毒关键病毒基因的表达。
Int J Biol Sci. 2021 Apr 10;17(6):1521-1529. doi: 10.7150/ijbs.59151. eCollection 2021.
9
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest.预测针对 SARS-CoV-2 株(包括关注和感兴趣的变体)的潜在有效 siRNA。
Future Microbiol. 2022 Apr;17:449-463. doi: 10.2217/fmb-2021-0130. Epub 2022 Mar 14.
10
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.用于 COVID-19 的靶向 SARS-CoV-2 的 siRNA-纳米颗粒治疗。
Mol Ther. 2021 Jul 7;29(7):2219-2226. doi: 10.1016/j.ymthe.2021.05.004. Epub 2021 May 14.

引用本文的文献

1
In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2.用于抑制新型冠状病毒2(SARS-CoV-2)的新型小干扰RNA(siRNA)的计算机模拟和体外开发
Comput Struct Biotechnol J. 2025 Mar 23;27:1460-1471. doi: 10.1016/j.csbj.2025.03.034. eCollection 2025.
2
Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences.自组装 siRNA 纳米颗粒靶向多个高度保守病毒序列抑制 SARS-CoV-2 复制。
Viruses. 2024 Jul 3;16(7):1072. doi: 10.3390/v16071072.
3
Approach: Design an Optimized shRNA against RUNX1 Gene to Target HIV.

本文引用的文献

1
Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation.用修饰后的 siRNA-肽树状聚合物制剂沉默 SARS-CoV-2。
Allergy. 2021 Sep;76(9):2840-2854. doi: 10.1111/all.14850. Epub 2021 May 10.
2
Alarming COVID variants show vital role of genomic surveillance.令人担忧的新冠病毒变种凸显了基因组监测的重要作用。
Nature. 2021 Jan;589(7842):337-338. doi: 10.1038/d41586-021-00065-4.
3
Prospects for RNAi Therapy of COVID-19.新冠病毒病的RNA干扰疗法前景
方法:设计一种针对RUNX1基因的优化短发夹RNA以靶向HIV。
Curr Drug Discov Technol. 2025;22(3):e250424229316. doi: 10.2174/0115701638291312240415151051.
4
Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis.复杂两亲性聚(多聚精胺丙烯酰胺)介导的肺部 siRNA 递送来治疗肺纤维化。
Small. 2024 May;20(22):e2308775. doi: 10.1002/smll.202308775. Epub 2023 Dec 21.
5
Pathogen regulatory RNA usage enables chronic infections, T-cell exhaustion and accelerated T-cell exhaustion.病原体调控RNA的利用会导致慢性感染、T细胞耗竭以及加速T细胞耗竭。
Mol Cell Biochem. 2023 Nov;478(11):2505-2516. doi: 10.1007/s11010-023-04680-9. Epub 2023 Mar 21.
6
Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions.基于微流控技术的 COVID-19 诊断、预防和治疗:最新进展和未来方向。
Biomed Microdevices. 2023 Mar 13;25(2):10. doi: 10.1007/s10544-023-00649-z.
7
Potential of siRNA in COVID-19 therapy: Emphasis on design and nanoparticles based delivery.siRNA在COVID-19治疗中的潜力:重点在于设计和基于纳米颗粒的递送。
Front Bioeng Biotechnol. 2023 Feb 6;11:1112755. doi: 10.3389/fbioe.2023.1112755. eCollection 2023.
8
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms.预知下一步棋:阻断 SARS-CoV-2 复制并同时解除病毒逃逸机制。
Genes (Basel). 2022 Nov 18;13(11):2147. doi: 10.3390/genes13112147.
9
XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection.靶向 SARS-CoV-2 基因组的 XNAzymes 抑制病毒感染。
Nat Commun. 2022 Nov 16;13(1):6716. doi: 10.1038/s41467-022-34339-w.
10
Keeping up with the COVID's-Could siRNA-based antivirals be a part of the answer?紧跟新冠疫情——基于小干扰RNA的抗病毒药物会是解决方案的一部分吗?
Exploration (Beijing). 2022 Jul 14;2(6):20220012. doi: 10.1002/EXP.20220012.
Front Bioeng Biotechnol. 2020 Jul 30;8:916. doi: 10.3389/fbioe.2020.00916. eCollection 2020.
4
Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的基因组多样性、泛基因组和进化。
PeerJ. 2020 Jul 17;8:e9576. doi: 10.7717/peerj.9576. eCollection 2020.
5
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.
6
Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.新冠病毒(SARS-CoV-2)的基因变异可能解释了新冠肺炎(COVID-19)严重程度的差异。
Med Hypotheses. 2020 Oct;143:109877. doi: 10.1016/j.mehy.2020.109877. Epub 2020 May 24.
7
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和严重急性呼吸综合征冠状病毒 2(COVID-19)治疗:专利述评。
Expert Opin Ther Pat. 2020 Aug;30(8):567-579. doi: 10.1080/13543776.2020.1772231. Epub 2020 Jun 7.
8
siRNA could be a potential therapy for COVID-19.小干扰RNA可能是一种治疗新冠肺炎的潜在疗法。
EXCLI J. 2020 Apr 22;19:528-531. doi: 10.17179/excli2020-1328. eCollection 2020.
9
Coronavirus Pandemic-Therapy and Vaccines.冠状病毒大流行——治疗方法与疫苗
Biomedicines. 2020 May 3;8(5):109. doi: 10.3390/biomedicines8050109.
10
Computational Identification of Small Interfering RNA Targets in SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中小干扰RNA靶点的计算鉴定
Virol Sin. 2020 Jun;35(3):359-361. doi: 10.1007/s12250-020-00221-6. Epub 2020 Apr 15.